Duodenal Neuroendocrine Tumor
NCI Definition: A well differentiated, low or intermediate grade tumor with neuroendocrine differentiation that arises from the duodenum. 
There are 2 clinical trials for duodenal neuroendocrine tumor, of which 2 are open and 0 are completed or closed. Of the trials that contain duodenal neuroendocrine tumor as an inclusion criterion, 2 are phase 2 (2 open).
Abemaciclib, everolimus, and ribociclib are the most common interventions in duodenal neuroendocrine tumor clinical trials.
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.